497 related articles for article (PubMed ID: 2529962)
21. Disposition of the antipsychotic agent CI-1007 in rats, monkeys, dogs, and human cytochrome P450 2D6 extensive metabolizers. Species comparison and allometric scaling.
Feng MR; Loo J; Wright J
Drug Metab Dispos; 1998 Oct; 26(10):982-8. PubMed ID: 9763403
[TBL] [Abstract][Full Text] [Related]
22. Species differences in the metabolism and disposition of spironolactone.
Karim A; Kook C; Zitzewitz DJ; Zagarella J; Doherty M; Campion J
Drug Metab Dispos; 1976; 4(6):547-55. PubMed ID: 11976
[TBL] [Abstract][Full Text] [Related]
23. Disposition and metabolism of [14C]brasofensine in rats, monkeys, and humans.
Zhu M; Whigan DB; Chang SY; Dockens RC
Drug Metab Dispos; 2008 Jan; 36(1):24-35. PubMed ID: 17908924
[TBL] [Abstract][Full Text] [Related]
24. Disposition of the novel anticancer agent vinorelbine ditartrate following intravenous administration in mice, rats and dogs.
Kobayashi S; Sakai T; Dalrymple PD; Wood SG; Chasseaud LF
Arzneimittelforschung; 1993 Dec; 43(12):1367-77. PubMed ID: 8141830
[TBL] [Abstract][Full Text] [Related]
25. Species and organ differences in first-pass metabolism of the ester prodrug L-751,164 in dogs and monkeys. In vivo and in vitro studies.
Prueksaritanont T; Gorham LM; Ellis JD; Fernandez-Metzler C; Deluna P; Gehret JR; Strong KL; Hochman JH; Askew BC; Duggan ME; Gilbert JD; Lin JH; Vyas KP
Drug Metab Dispos; 1996 Nov; 24(11):1263-71. PubMed ID: 8937862
[TBL] [Abstract][Full Text] [Related]
26. Disposition of abouthiouzine: a novel antihyperthyroid drug.
Alkharfy KM; Khan RM; Al-Hadiya BM; Abou-Auda HS; Abou-Shaaban RR
Biopharm Drug Dispos; 2007 Apr; 28(3):105-11. PubMed ID: 17230598
[TBL] [Abstract][Full Text] [Related]
27. Pharmacokinetics and pharmacodynamics of the acetylcholinesterase inhibitor 2,2,2-trifluoro-1-(3-trimethylsilylphenyl) ethanone in dog. Potential for transdermal patch delivery.
Dow J; Dulery BD; Hornsperger JM; Di Francesco GF; Keshary P; Haegele KD
Arzneimittelforschung; 1995 Dec; 45(12):1245-52. PubMed ID: 8595078
[TBL] [Abstract][Full Text] [Related]
28. Excretion and metabolism of recainam, a new anti-arrhythmic drug, in laboratory animals and humans.
Scatina JA; Wells DS; Kimmel HB; Kemper CJ; Sisenwine SF
Drug Metab Dispos; 1990; 18(5):746-52. PubMed ID: 1981731
[TBL] [Abstract][Full Text] [Related]
29. Pharmacokinetics of PFA (trisodium phosphonoformate) after i.v. and p.o. administration to beagle dogs and rabbits.
Ritschel WA; Grummich KW; Hussain SA
Methods Find Exp Clin Pharmacol; 1985 Jan; 7(1):41-8. PubMed ID: 3157841
[TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics of a tumor necrosis factor-alpha phosphorothioate 2'-O-(2-methoxyethyl) modified antisense oligonucleotide: comparison across species.
Geary RS; Yu RZ; Watanabe T; Henry SP; Hardee GE; Chappell A; Matson J; Sasmor H; Cummins L; Levin AA
Drug Metab Dispos; 2003 Nov; 31(11):1419-28. PubMed ID: 14570775
[TBL] [Abstract][Full Text] [Related]
31. HPLC-NMR with severe column overloading: fast-track metabolite identification in urine and bile samples from rat and dog treated with [14C]-ZD6126.
Lenz EM; D'Souza RA; Jordan AC; King CD; Smith SM; Phillips PJ; McCormick AD; Roberts DW
J Pharm Biomed Anal; 2007 Feb; 43(3):1065-77. PubMed ID: 17030109
[TBL] [Abstract][Full Text] [Related]
32. Pharmacokinetics of the gastrokinetic agent mosapride citrate after intravenous and oral administrations in dogs and monkeys.
Sakashita M; Mizuki Y; Yamaguchi T; Miyazaki H; Sekine Y
Arzneimittelforschung; 1993 Aug; 43(8):864-6. PubMed ID: 8216444
[TBL] [Abstract][Full Text] [Related]
33. Effects of formulation and route of administration on the systemic availability of Ex-RAD®, a new radioprotectant, in preclinical species.
Chun AW; Freshwater RE; Taft DR; Gillum AM; Maniar M
Biopharm Drug Dispos; 2011 Mar; 32(2):99-111. PubMed ID: 21341279
[TBL] [Abstract][Full Text] [Related]
34. Pharmacokinetics of tolterodine, a muscarinic receptor antagonist, in mouse, rat and dog. Interspecies relationship comparing with human pharmacokinetics.
Påhlman I; Kankaanranta S; Palmér L
Arzneimittelforschung; 2001 Feb; 51(2):134-44. PubMed ID: 11258043
[TBL] [Abstract][Full Text] [Related]
35. Pharmacokinetics of nisoldipine. I. Absorption, concentration in plasma, and excretion after single administration of [14C]nisoldipine in rats, dogs, monkey, and swine.
Ahr HJ; Krause HP; Siefert HM; Suwelack D; Weber H
Arzneimittelforschung; 1988 Aug; 38(8):1093-8. PubMed ID: 3196402
[TBL] [Abstract][Full Text] [Related]
36. Pharmacokinetics of N-nitrosodimethylamine in beagles.
Gombar CT; Pylypiw HM; Harrington GW
Cancer Res; 1987 Jan; 47(2):343-7. PubMed ID: 3791224
[TBL] [Abstract][Full Text] [Related]
37. Metabolic disposition of 14C-venlafaxine in mouse, rat, dog, rhesus monkey and man.
Howell SR; Husbands GE; Scatina JA; Sisenwine SF
Xenobiotica; 1993 Apr; 23(4):349-59. PubMed ID: 8337893
[TBL] [Abstract][Full Text] [Related]
38. Interspecies comparison of acivicin pharmacokinetics.
McGovren JP; Williams MG; Stewart JC
Drug Metab Dispos; 1988; 16(1):18-22. PubMed ID: 2894949
[TBL] [Abstract][Full Text] [Related]
39. Biotransformation of a novel antimitotic agent, I-387, by mouse, rat, dog, monkey, and human liver microsomes and in vivo pharmacokinetics in mice.
Ahn S; Kearbey JD; Li CM; Duke CB; Miller DD; Dalton JT
Drug Metab Dispos; 2011 Apr; 39(4):636-43. PubMed ID: 21233217
[TBL] [Abstract][Full Text] [Related]
40. The absorption, distribution, metabolism and excretion of rofecoxib, a potent and selective cyclooxygenase-2 inhibitor, in rats and dogs.
Halpin RA; Geer LA; Zhang KE; Marks TM; Dean DC; Jones AN; Melillo D; Doss G; Vyas KP
Drug Metab Dispos; 2000 Oct; 28(10):1244-54. PubMed ID: 10997947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]